Literature DB >> 17703709

Self-medication hypothesis of substance use: testing Khantzian's updated theory.

Danny H Hall1, John E Queener.   

Abstract

Substance use research has been a salient focus for mental health professionals in recent years. Several organizations, including the American Psychological Association, have been pressing for more substance use research, particularly clinically relevant, theory-based investigations. However, there are few theories of substance use, and even fewer with scientific support. One theory is the Self Medication Hypothesis by Khantzian (1977, 1974), a theory with 30 years of research. However, recent modifications in Khantzian's theory (1999) have not been properly tested. Specifically, two areas require further investigation: Khantzian's belief that more negative affect should be related directly to more substance use, and expanding the number of affective states examined, including alexithymia, to better operationalize Khantzian's belief that several painful and ambiguous forms of affect may be implicated in the self-medicating process. The current study assessed anxiety, depression, hostility and alexithymia levels in 70 methadone maintenance treatment patients. Results indicated that affective measures did not have the expected relationship with reported substance use. The authors advocate for the exploration of multiple factors, not merely emotional regulation, in the variability of substance use.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703709     DOI: 10.1080/02791072.2007.10399873

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  9 in total

1.  Heterogeneity in the Co-occurrence of Substance Use and Posttraumatic Stress Disorder: A Latent Class Analysis Approach.

Authors:  Ateka A Contractor; Nicole H Weiss; Katherine L Dixon-Gordon; Heidemarie Blumenthal
Journal:  J Dual Diagn       Date:  2019-03-06

Review 2.  The self-medication hypothesis and psychostimulant treatment of cocaine dependence: an update.

Authors:  John J Mariani; Edward J Khantzian; Frances R Levin
Journal:  Am J Addict       Date:  2013-09-13

3.  A preliminary examination of cortical neurotransmitter levels associated with heavy drinking in posttraumatic stress disorder.

Authors:  David Louis Pennington; Christoph Abé; Steven Laszlo Batki; Dieter Johannes Meyerhoff
Journal:  Psychiatry Res       Date:  2014-09-16       Impact factor: 3.222

4.  Low dispositional mindfulness predicts self-medication of negative emotion with prescription opioids.

Authors:  Eric L Garland; Adam W Hanley; Elizabeth A Thomas; Paul Knoll; Jeffrey Ferraro
Journal:  J Addict Med       Date:  2015 Jan-Feb       Impact factor: 3.702

Review 5.  Brain interrupted: Early life traumatic brain injury and addiction vulnerability.

Authors:  Lee Anne Cannella; Hannah McGary; Servio H Ramirez
Journal:  Exp Neurol       Date:  2019-03-09       Impact factor: 5.330

6.  The moderating effects of perceived emotional benefits on inhalant initiation among American Indian and white youth.

Authors:  Randall C Swaim
Journal:  Am J Addict       Date:  2015-08-05

7.  Motives for prescription opioid use: The role of alexithymia and distress tolerance.

Authors:  Aisling V Henschel; Julianne C Flanagan; Isabel F Augur; Stephanie M Jeffirs; Sudie E Back
Journal:  Am J Addict       Date:  2021-09-27

8.  Is 'self-medication' a useful term to retrieve related publications in the literature? A systematic exploration of related terms.

Authors:  Ava Mansouri; Amir Sarayani; Asieh Ashouri; Mona Sherafatmand; Molouk Hadjibabaie; Kheirollah Gholami
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

9.  Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms.

Authors:  Petra Amchova; Jana Kucerova; Valentina Giugliano; Zuzana Babinska; Mary T Zanda; Maria Scherma; Ladislav Dusek; Paola Fadda; Vincenzo Micale; Alexandra Sulcova; Walter Fratta; Liana Fattore
Journal:  Front Pharmacol       Date:  2014-03-20       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.